U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929364) titled 'The Role of Probiotics in the Treatment of Endometriosis (ProMetrioS): a Randomised Double-blinded Placebo-controlled Cross-over Trial' on Sept. 17, 2024.
Brief Summary: ProMetrioS is a randomised blinded placebo-controlled cross-over trial investigating the effect of specific multistrain probiotics in patients with endometriosis. The aim of this clinical trial is to determine whether probiotic treatment can significantly modulate gut microbiome composition and functionality in endometriosis patients, specifically parameters associated with the estrobolome.
Study Start Date: Nov. 01, 2024
Study Type: INTERVENTIONAL
Condition:
E...